Showing results (41-50 of 1,291) with videos related to
Sort By:
Pageof 130
Journal of Biopharmaceutical Statistics|February 26, 2010
Noninferiority trial design and analysis with an ordered three-level categorical endpointErica Brittain, Zonghui HuStatistics and Its Interface|September 28, 2011
Semiparametric latent covariate mixed-effects models with application to a colon carcinogenesis studyZonghui Hu, Naisyin WangMedrxiv : the Preprint Server for Health Sciences|September 8, 2021
Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is VaccinatedDean Follmann, Michael Fay, Craig Magaret, et al.Statistics in Medicine|June 10, 2021
The mechanistic analysis of founder virus data in challenge modelsAna M Ortega-Villa, Martha C Nason, Dean FollmannTransfusion|April 19, 2003
G-CSF-induced spleen size changes in peripheral blood progenitor cell donorsDavid Stroncek, Thomas Shawker, Dean Follmann, et al.Statistics in Medicine|December 21, 2019
Analysis of ordered composite endpointsDean Follmann, Michael P Fay, Toshimitsu Hamasaki, et al.The Annals of Applied Statistics|December 17, 2008
ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODELLi Qin, Peter B Gilbert, Dean Follmann, et al.JAMA|March 8, 2003
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcomeStephen Rosenfeld, Dean Follmann, Olga Nunez, et al.The International Journal of Biostatistics|April 17, 2019
Estimating the Population Average Treatment Effect in Observational Studies with Choice-Based SamplingZhiwei Zhang, Zonghui Hu, Chunling LiuStatistical Communications in Infectious Diseases|March 30, 2019
Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze?Scott Evans, Daniel B Rubin, John H Powers, et al.Pageof 130